Bristol-Myers Squibb (BMY) Raises Quarterly Dividend 2.5% to $0.41; 3.1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
- Wall Street posts weekly gains with earnings, inflation data on tap
Bristol-Myers Squibb (BMY), Vedanta Biosciences Report New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) & VE800 in Patients with Advanced or Metastatic Cancers
December 10, 2018 5:56 AM ESTBristol-Myers Squibb Company (NYSE: BMY) and Vedanta Biosciences today announced a clinical trial collaboration to evaluate Bristol-Myers... More
BMO Capital Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
December 6, 2018 3:59 AM ESTBMO Capital analyst Alex Arfaei upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Market Perform to Outperform with a price target of $60.00 (from $56.00).
The analyst upgrades the name citing expectations for upside to consensus IO and Margin estimates.
Arfaei commented, "The... More



